X

  • JaeMun Choi
  • CEO
  • Calici Co., Ltd

Curriculum Vitae

Education

BA, Korea University, Korea (1991)
MS, Korea University, Korea (2001)
Ph.D., Baylor college of Medicine (2005)

Professional Experience

Adjunct professor, Korea University (2023 ~ present)
Adjunct professor, ChungNam University (2022 ~ present)
CEO, Calici Co., Ltd (2020 ~ present)

Research Interests

AI drug discovery platform, AI-SaaS, Lead Optimization, ADME-Tox prediction

Honors & Awards

1) Selected for the Ministry of Science and ICT's Global ICT Future Unicorn Program
2) Awarded the Star Company Prize at the 12th Kibo Venture Camp
3) Received the 2022 Innovative Korean & Power Korea Grand Prize

Publications

1) ETV5 reduces androgen receptor expression and induces neural stem–like properties during neuroendocrine prostate cancer development. PNAS 122(12):e2420313122
2) Prediction model of browning inhibitor concentration and its optimal composition for mass processing of ready-to-eat fresh-cut 'Fuji' apple (Malus domestica Borkh.) strains.
J Food Sci 89(8):4986
3) Optimizing PROTAC Design: A Novel Approach Using Exposure Scores for Linker Site Selection. IEEE 20025, 9-12



 

 

  Close